EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma

Abstract

Authors

T Martin SZ Usmani N Joseph C Crivera S Valluri CC Jackson L Cohen S Singh S Jagannath

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×